Citations

Showing 1-6 of 6
Journal Article
Villar, J., R. Ochieng, E. Staines-Urias, M. Fernandes, M. Ratcliff, M. Purwar, F. Barros, B. Horta, L. Cheikh Ismail, E. Albernaz, N. Kunnawar, S. Temple, F. Giuliani, T. Sandells, M. Carvalho, E. Ohuma, Y. Jaffer, J. Alison Noble, M. Gravett, R. Pang, A. Lambert, E. Bertino, P. Di Nicola, A. Papageorghiou, A. Stein, Z. Bhutta, and S. Kennedy. "Late weaning and maternal closeness, associated with advanced motor and visual maturation, reinforce autonomy in healthy, 2-year-old children." Sci Rep 10, no. 1 (2020).
Journal Article
Tugendhaft, A., K. Hofman, M. Danis, K. Kahn, A. Erzse, R. Twine, M. Gold, and N. Christofides. "Deliberative engagement methods on health care priority-setting in a rural South African community." Health Policy Plan 36, no. 8 (2021): 1279-1291.
Journal Article
Hanifa, Y., K. L Fielding, V. N Chihota, L. Adonis, S. Charalambous, N. Foster, A. Karstaedt, K. McCarthy, M. P Nicol, N. T Ndlovu, E. Sinanovic, F. Sahid, W. Stevens, A. Vassall, G. J Churchyard, and A. D Grant. "A clinical scoring system to prioritise investigation for tuberculosis among adults attending HIV clinics in South Africa." PLoS One 12, no. 8 (2017).
Journal Article
El Bouzidi, K., E. White, J. L Mbisa, C. A Sabin, A. N Phillips, N. Mackie, A. L Pozniak, A. Tostevin, D. Pillay, D. T Dunn, Uk Hiv Drug Resistance Database, and the, U. K. Collaborative H. I. V. Cohort Study Steering Committees, Uk Hiv Drug Resistance Database, and the, U. K. Collaborative H. I. V. Cohort Study Steering Committees. "HIV-1 drug resistance mutations emerging on darunavir therapy in PI-naive and -experienced patients in the UK." J Antimicrob Chemother 71, no. 12 (2016): 3487-3494.
Journal Article
Schultze, A., R. Paredes, C. Sabin, A. N Phillips, D. Pillay, N. Mackie, A. Castagna, D. Chadwick, K. Falconer, A. M Geretti, F. A Post, T. Hill, O. Kirk, A. Pozniak, M. Nelson, A. Tostevin, D. Dunn, J. Lundgren, and A. Cozzi-Lepri. "The association between detected drug resistance mutations and CD4(+) T-cell decline in HIV-positive individuals maintained on a failing treatment regimen." Antivir Ther 23, no. 2 (2018): 105-116.
Journal Article
Vassall, A., M. Siapka, N. Foster, L. Cunnama, L. Ramma, K. Fielding, K. McCarthy, G. Churchyard, A. Grant, and E. Sinanovic. "Cost-effectiveness of Xpert MTB/RIF for tuberculosis diagnosis in South Africa: a real-world cost analysis and economic evaluation." Lancet Glob Health 5, no. 7 (2017): e710-e719.
Showing 1-6 of 6